位置:首页 > 蛋白库 > BCS1_HAEIF
BCS1_HAEIF
ID   BCS1_HAEIF              Reviewed;         474 AA.
AC   Q48230;
DT   05-OCT-2016, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-MAY-2022, entry version 105.
DE   RecName: Full=Bifunctional ribulose 5-phosphate reductase/CDP-ribitol pyrophosphorylase Bcs1 {ECO:0000305};
DE   AltName: Full=CDP-ribitol synthase {ECO:0000303|PubMed:11305920};
DE   Includes:
DE     RecName: Full=Ribitol-5-phosphate cytidylyltransferase {ECO:0000303|PubMed:11305920};
DE              EC=2.7.7.40 {ECO:0000269|PubMed:11305920, ECO:0000269|PubMed:15362865};
DE   Includes:
DE     RecName: Full=Ribulose-5-phosphate reductase {ECO:0000303|PubMed:11305920};
DE              Short=Ribulose-5-P reductase {ECO:0000305};
DE              EC=1.1.1.405 {ECO:0000269|PubMed:11305920, ECO:0000269|PubMed:15362865};
DE     AltName: Full=Ribitol-5-phosphate dehydrogenase {ECO:0000305};
GN   Name=bcs1 {ECO:0000312|EMBL:AAP42161.1};
OS   Haemophilus influenzae.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pasteurellales;
OC   Pasteurellaceae; Haemophilus.
OX   NCBI_TaxID=727 {ECO:0000312|EMBL:CAA55303.1};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=RM135 {ECO:0000312|EMBL:CAA55303.1};
RX   PubMed=7752885; DOI=10.1111/j.1365-2958.1995.tb02225.x;
RA   van Eldere J., Brophy L., Loynds B., Celis P., Kroll J.S., Moxon E.R.,
RA   Hancock I., Carman S.;
RT   "Region II of Haemophilus influenzae type b capsulation locus is involved
RT   in serotype-specific polysaccharide synthesis.";
RL   Mol. Microbiol. 15:107-118(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=373 / Serotype B {ECO:0000312|EMBL:AAP42171.1}, and
RC   GA834 / Serotype B {ECO:0000312|EMBL:AAP42161.1};
RX   PubMed=12761153; DOI=10.1128/iai.71.6.3639-3644.2003;
RA   Satola S.W., Schirmer P.L., Farley M.M.;
RT   "Complete sequence of the cap locus of Haemophilus influenzae serotype b
RT   and nonencapsulated b capsule-negative variants.";
RL   Infect. Immun. 71:3639-3644(2003).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBUNIT, AND MUTAGENESIS OF ARG-18 AND LYS-386.
RX   PubMed=11305920; DOI=10.1021/bi002745n;
RA   Zolli M., Kobric D.J., Brown E.D.;
RT   "Reduction precedes cytidylyl transfer without substrate channeling in
RT   distinct active sites of the bifunctional CDP-ribitol synthase from
RT   Haemophilus influenzae.";
RL   Biochemistry 40:5041-5048(2001).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   ENZYME KINETICS.
RX   PubMed=15362865; DOI=10.1021/bi048866v;
RA   Pereira M.P., Brown E.D.;
RT   "Bifunctional catalysis by CDP-ribitol synthase: convergent recruitment of
RT   reductase and cytidylyltransferase activities in Haemophilus influenzae and
RT   Staphylococcus aureus.";
RL   Biochemistry 43:11802-11812(2004).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent reduction of D-ribulose 5-
CC       phosphate to D-ribitol 5-phosphate and the further reaction of D-
CC       ribitol 5-phosphate with CTP to form CDP-ribitol.
CC       {ECO:0000269|PubMed:11305920, ECO:0000269|PubMed:15362865}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=CTP + D-ribitol 5-phosphate + H(+) = CDP-L-ribitol +
CC         diphosphate; Xref=Rhea:RHEA:12456, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:37563, ChEBI:CHEBI:57608,
CC         ChEBI:CHEBI:57695; EC=2.7.7.40;
CC         Evidence={ECO:0000269|PubMed:11305920, ECO:0000269|PubMed:15362865};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-ribitol 5-phosphate + NADP(+) = D-ribulose 5-phosphate +
CC         H(+) + NADPH; Xref=Rhea:RHEA:19921, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57695, ChEBI:CHEBI:57783, ChEBI:CHEBI:58121,
CC         ChEBI:CHEBI:58349; EC=1.1.1.405;
CC         Evidence={ECO:0000269|PubMed:11305920, ECO:0000269|PubMed:15362865};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=42 uM for D-ribulose 5-phosphate {ECO:0000269|PubMed:11305920};
CC         KM=106 uM for D-ribulose 5-phosphate {ECO:0000269|PubMed:15362865};
CC         KM=25 uM for NADPH {ECO:0000269|PubMed:11305920};
CC         KM=7.06 uM for NADPH {ECO:0000269|PubMed:15362865};
CC         KM=75 uM for D-ribitol 5-phosphate (for the cytidylyltransferase
CC         reaction) {ECO:0000269|PubMed:11305920};
CC         KM=14.7 uM for D-ribitol 5-phosphate (for the cytidylyltransferase
CC         reaction) {ECO:0000269|PubMed:15362865};
CC         KM=74 uM for CTP {ECO:0000269|PubMed:11305920};
CC         KM=8.51 uM for CTP {ECO:0000269|PubMed:15362865};
CC         Note=kcat is 22 sec(-1) for the reductase reaction. kcat is 13 sec(-
CC         1) for the cytidyltransferase reaction.
CC         {ECO:0000269|PubMed:11305920};
CC   -!- PATHWAY: Capsule biogenesis; capsule polysaccharide biosynthesis.
CC       {ECO:0000305}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:11305920,
CC       ECO:0000269|PubMed:15362865}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the IspD/TarI
CC       cytidylyltransferase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the short-chain
CC       dehydrogenases/reductases (SDR) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF549210; AAP42161.1; -; Genomic_DNA.
DR   EMBL; AF549212; AAP42171.1; -; Genomic_DNA.
DR   EMBL; X78559; CAA55303.1; -; Genomic_DNA.
DR   PIR; S60902; S60902.
DR   AlphaFoldDB; Q48230; -.
DR   SMR; Q48230; -.
DR   BRENDA; 1.1.1.405; 2529.
DR   SABIO-RK; Q48230; -.
DR   UniPathway; UPA00934; -.
DR   GO; GO:0050518; F:2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0047349; F:D-ribitol-5-phosphate cytidylyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0045227; P:capsule polysaccharide biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0016114; P:terpenoid biosynthetic process; IEA:UniProtKB-UniRule.
DR   CDD; cd02516; CDP-ME_synthetase; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   HAMAP; MF_00108; IspD; 1.
DR   InterPro; IPR012115; CDP-ribitol_syn.
DR   InterPro; IPR001228; IspD.
DR   InterPro; IPR034683; IspD/TarI.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF01128; IspD; 1.
DR   PIRSF; PIRSF036586; CDP-ribitol_syn; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   Capsule biogenesis/degradation; NADP; Nucleotidyltransferase;
KW   Oxidoreductase; Transferase.
FT   CHAIN           1..474
FT                   /note="Bifunctional ribulose 5-phosphate reductase/CDP-
FT                   ribitol pyrophosphorylase Bcs1"
FT                   /id="PRO_0000437506"
FT   REGION          1..238
FT                   /note="Ribitol-5-phosphate cytidylyltransferase"
FT   REGION          250..474
FT                   /note="Ribulose-5-phosphate reductase"
FT   MUTAGEN         18
FT                   /note="R->A: Has 100-fold reduction of catalytic efficiency
FT                   for the cytidylyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:11305920"
FT   MUTAGEN         386
FT                   /note="K->A: Has 70-fold reduction of catalytic efficiency
FT                   for the reductase activity."
FT                   /evidence="ECO:0000269|PubMed:11305920"
SQ   SEQUENCE   474 AA;  52467 MW;  DC42A2B245318A95 CRC64;
     MNKNKNIGII LAGGVGSRMG LGYPKQFSKI AGKTALEHTL AIFQEHKEID EIIIVSERTS
     YRRIEDIVSK LDFSKVNRII FGGKERSDST LSAITALQDE PENTKLIIHD AVRPLLATEI
     ISECIAKLDK YNAVDVAIPA VDTIVHVNND TQEIIKIPKR AEYYQGQTPQ AFKLGTLKKA
     YDIYTQGGIE GTCDCSIVLK TLPEERVGIV SGSETNIKLT RPVDLFIADK LFQSRSHFSL
     RNITSIDRLY DMKDQVLVVI GGSYGIGAHI IDIAKKFGIK TYSLSRSNGV DVGDVKSIEK
     AFAEIYAKEH KIDHIVNTAA VLNHKTLVSM SYEEILTSIN VNYTGMINAV ITAYPYLKQT
     HGSFLGFTSS SYTRGRPFYA IYSSAKAAVV NLTQAISEEW LPDNIKINCV NPERTKTPMR
     TKAFGIEPEG TLLDAKTVAF ASLVVLASRE TGNIIDVVLK DEEYITNILA DLYK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024